An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
التنسيق:	Journal article
اللغة:	English
منشور في:	1998

مواد مشابهة

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
حسب: Cerundolo, V, وآخرون
منشور في: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
حسب: Kelleher, A, وآخرون
منشور في: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
حسب: Gileadi, U, وآخرون
منشور في: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
حسب: Klenerman, P, وآخرون
منشور في: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
حسب: Anjali K. Gupta, وآخرون
منشور في: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
حسب: Milicic, A, وآخرون
منشور في: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
حسب: Atul Pawar, وآخرون
منشور في: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
حسب: Valmori, D, وآخرون
منشور في: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
حسب: Sham, Hoi Fung
منشور في: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
حسب: Cerundolo, V, وآخرون
منشور في: (1997)

Current and Novel Inhibitors of HIV Protease
حسب: Jan Konvalinka, وآخرون
منشور في: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
حسب: Johanna Bialas, وآخرون
منشور في: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
حسب: Kourjian G, وآخرون
منشور في: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
حسب: Jorissen, Robert N., وآخرون
منشور في: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
حسب: V.B. Denisenko, وآخرون
منشور في: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
حسب: V.B. Denisenko, وآخرون
منشور في: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
حسب: Murray, R, وآخرون
منشور في: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
حسب: Valmori, D, وآخرون
منشور في: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
حسب: Gupta, A, وآخرون
منشور في: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
حسب: Larissa da Costa Souza, وآخرون
منشور في: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
حسب: S. V. Semochkin
منشور في: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
حسب: Romério Rodrigues dos Santos Silva, وآخرون
منشور في: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
حسب: Fabrizio Mammano, وآخرون
منشور في: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
حسب: Roberta Rinaldi, وآخرون
منشور في: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
حسب: Abhilash I. Chiramel, وآخرون
منشور في: (2019-06-01)

Site-Specific Proteasome Inhibitors
حسب: Alexei F. Kisselev
منشور في: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
حسب: Noah M. Merin, وآخرون
منشور في: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
حسب: Christoph Driessen, وآخرون
منشور في: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
حسب: Hemelaar, J, وآخرون
منشور في: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
حسب: Nathalie Vigneron, وآخرون
منشور في: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
حسب: Tran Linh, وآخرون
منشور في: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
حسب: Chougrani I, وآخرون
منشور في: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
حسب: Kathleen M S E Reyskens, وآخرون
منشور في: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
حسب: Konvalinka Jan, وآخرون
منشور في: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
حسب: Kann G, وآخرون
منشور في: (2021-08-01)

Immune surveillance and AIDS progression.
حسب: Zinkernagel, R, وآخرون
منشور في: (1997)

Correspondence - Immune surveillance and AIDS progression
حسب: Zinkernagel, R, وآخرون
منشور في: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
حسب: Klenerman, P, وآخرون
منشور في: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
حسب: Klenerman, P, وآخرون
منشور في: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
حسب: J. Lopes, وآخرون
منشور في: (2021-04-01)